01 7Geninax
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 31
2019 Revenue in Millions : 75
Growth (%) : -59
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 22
2020 Revenue in Millions : 31
Growth (%) : -24
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 4
2021 Revenue in Millions : 22
Growth (%) : -83
Main Therapeutic Indication : Anti-Bacterial
Currency : USD
2018 Revenue in Millions : 77
2017 Revenue in Millions : 85
Growth (%) : -9%
Main Therapeutic Indication : Anti-Bacterial
Currency : USD
2016 Revenue in Millions : 91
2015 Revenue in Millions : 98
Growth (%) : -7
Main Therapeutic Indication : Anti-bacterial
Currency : USD
2017 Revenue in Millions : 90
2016 Revenue in Millions : 97
Growth (%) : -7
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2019 Revenue in Millions : 76
2018 Revenue in Millions : 80
Growth (%) : -5
LOOKING FOR A SUPPLIER?
